Bausch & Lomb (BLCO) Shares Outstanding (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Shares Outstanding (Entity) came in at $357.1 million in Q2 2026, up 0.92% on a YoY basis from $353.8 million in Q2 2025, and little changed quarter-over-quarter from $356.4 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Shares Outstanding (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Shares Outstanding (Entity) for 6 consecutive years, with $357.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 0.92% year-over-year to $357.1 million; the trailing twelve-month figure through Jun 2026 stood at $357.1 million (up 0.92% YoY), and the FY2025 full-year result was $354.2 million, up 0.51% from the prior year.
- Shares Outstanding (Entity) held at $357.1 million in Q2 2026 per BLCO's latest filing, from $356.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $357.1 million in Q2 2026 and bottomed at $350.0 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $352.2 million across 5 years, with a median of $351.6 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) changed 0.0% in 2022, then gained 0.92% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $350.2 million in 2022, then advanced by 0.21% to $350.9 million in 2023, then rose by 0.42% to $352.4 million in 2024, then rose by 0.51% to $354.2 million in 2025, then climbed by 0.8% to $357.1 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $357.1 million, $356.4 million, and $354.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 357.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 357.10 Mn |
| Mar 31, 2026 | 355.20 Mn |
| Dec 31, 2025 | 353.80 Mn |
| Sep 30, 2025 | 354.20 Mn |
| Jun 30, 2025 | 353.70 Mn |
| Mar 31, 2025 | 352.80 Mn |
| Dec 31, 2024 | 351.80 Mn |
| Sep 30, 2024 | 351.90 Mn |
| Jun 30, 2024 | 351.80 Mn |
| Mar 31, 2024 | 351.10 Mn |
| Dec 31, 2023 | 350.50 Mn |
| Sep 30, 2023 | 350.80 Mn |
| Jun 30, 2023 | 350.50 Mn |
| Mar 31, 2023 | 350.00 Mn |
| Dec 31, 2022 | 350.00 Mn |
| Sep 30, 2022 | 350.00 Mn |
| Jun 30, 2022 | 350.00 Mn |
| Mar 31, 2022 | 350.00 Mn |
| Dec 31, 2021 | 350.00 Mn |
| Sep 30, 2021 | 350.00 Mn |